The Effect of Small Wins on Body Fat Loss

NCT04973072 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2022-04-26

No results posted yet for this study

Summary

This 24-week-long study compares the effectiveness of two finance incentive structures for weight loss: 1) smaller rewards for achieving intermediate goals vs 2) large reward for achieving an overall goal. Target participants are male Singaporeans or Permanent Residents who are overweight and otherwise healthy.

Conditions

Interventions

BEHAVIORAL

One large reward treatment

Participants will be awarded S$300 for reaching the PBF goal at the end of 12 weeks.

BEHAVIORAL

Small wins treatment

The cash rewards that participants will receive are capped by $300 and depend on which IGs they achieve and whether they maintain their progress at the end of the 12 weeks. Specifically, given the PBF goal, the Loss Target (LT) is the difference between the initial PBF measured at the first visit and the PBF goal, i.e., LT = initial PBF - PBF goal. Then, the IG1 is to achieve 25% of the LT, the IG2 is to achieve 50% of the LT, and the IG3 is to achieve 75% of the LT. Participants will earn $75 credits to their accounts on the programme website for reaching each intermediate goal. Also, when they miss IG1 and/or IG3, they can earn the previous missing $75 credits if they reach the IG2 and the LT. At the end of the 12 weeks, they will lose some or all the credits that they have accumulated if they fail to maintain the progress, and they will only receive the corresponding amount in cash

Sponsors & Collaborators

  • Noah Lim

    lead OTHER

Principal Investigators

  • Noah Lim, PhD · The Global Asia Institute, The National University of Singapore

  • Alessandro Del Ponte, PhD · Institution for Social and Policy Studies, Yale University

  • Ta-Cheng Huang, PhD · The Global Asia Institute, The National University of Singapore

  • Aidas Masiliunas, PhD · The Global Asia Institute, The National University of Singapore

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
60 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-13
Primary Completion
2023-01-31
Completion
2023-01-31

Countries

  • Singapore

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04973072 on ClinicalTrials.gov